OZEM vs. XPH ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to SPDR S&P Pharmaceuticals ETF (XPH)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$25.41
Average Daily Volume
38,199
14
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$46.29
Average Daily Volume
60,075
44
Performance
Period | OZEM | XPH |
---|---|---|
30 Days | -10.50% | -2.44% |
60 Days | -10.19% | 1.87% |
90 Days | -10.75% | 5.00% |
12 Months | 26.54% |
OZEM Underweight 41 Positions Relative to XPH
Symbol | Grade | Weight | |
---|---|---|---|
LBPH | A | -4.12% | |
BMY | B | -4.11% | |
ITCI | B | -4.01% | |
JAZZ | B | -3.94% | |
VTRS | A | -3.73% | |
AXSM | B | -3.59% | |
EWTX | C | -3.42% | |
CTLT | D | -3.41% | |
ELAN | D | -3.35% | |
PRGO | C | -3.35% | |
RPRX | D | -3.18% | |
JNJ | D | -3.17% | |
ZTS | D | -3.15% | |
MRK | F | -2.93% | |
TARS | C | -2.81% | |
OGN | F | -2.58% | |
SAVA | D | -2.57% | |
ARVN | F | -2.53% | |
PBH | A | -2.5% | |
SUPN | B | -2.15% | |
AMPH | F | -2.02% | |
PCRX | C | -1.91% | |
LGND | C | -1.77% | |
ANIP | D | -1.54% | |
COLL | F | -1.48% | |
OCUL | C | -1.44% | |
AMRX | C | -1.33% | |
MNMD | C | -1.23% | |
HRMY | F | -1.22% | |
WVE | C | -1.17% | |
HROW | D | -1.17% | |
INVA | D | -0.98% | |
EYPT | D | -0.94% | |
LQDA | F | -0.89% | |
PLRX | D | -0.87% | |
FULC | F | -0.85% | |
ELVN | C | -0.64% | |
NUVB | C | -0.6% | |
EOLS | F | -0.52% | |
PHAT | F | -0.48% | |
XERS | C | -0.46% |
OZEM: Top Represented Industries & Keywords
XPH: Top Represented Industries & Keywords